CN1390253A - 高级核酸型结构 - Google Patents

高级核酸型结构 Download PDF

Info

Publication number
CN1390253A
CN1390253A CN00815433A CN00815433A CN1390253A CN 1390253 A CN1390253 A CN 1390253A CN 00815433 A CN00815433 A CN 00815433A CN 00815433 A CN00815433 A CN 00815433A CN 1390253 A CN1390253 A CN 1390253A
Authority
CN
China
Prior art keywords
nucleic acid
molecule
polynucleotide
polynucleotide structure
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00815433A
Other languages
English (en)
Chinese (zh)
Inventor
F·J·卡尔
G·卡特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926810.4A external-priority patent/GB9926810D0/en
Priority claimed from GB0011126A external-priority patent/GB0011126D0/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CN1390253A publication Critical patent/CN1390253A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/52—Physical structure branched

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN00815433A 1999-11-13 2000-11-13 高级核酸型结构 Pending CN1390253A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9926810.4A GB9926810D0 (en) 1999-11-13 1999-11-13 High order nucleic acid-based structures
GB9926810.4 1999-11-13
GB0011126.0 2000-05-10
GB0011126A GB0011126D0 (en) 2000-05-10 2000-05-10 High order nucleic acid-based structures

Publications (1)

Publication Number Publication Date
CN1390253A true CN1390253A (zh) 2003-01-08

Family

ID=26244234

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00815433A Pending CN1390253A (zh) 1999-11-13 2000-11-13 高级核酸型结构

Country Status (16)

Country Link
EP (1) EP1228201A1 (pt)
JP (1) JP2003522524A (pt)
KR (1) KR20020059727A (pt)
CN (1) CN1390253A (pt)
AU (1) AU782880B2 (pt)
BR (1) BR0015484A (pt)
CA (1) CA2391084A1 (pt)
CZ (1) CZ20021472A3 (pt)
HK (1) HK1052529A1 (pt)
HU (1) HUP0203914A2 (pt)
MX (1) MXPA02004727A (pt)
NO (1) NO20022231D0 (pt)
PL (1) PL358811A1 (pt)
RU (1) RU2002113755A (pt)
SK (1) SK6042002A3 (pt)
WO (1) WO2001036624A1 (pt)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103889998A (zh) * 2011-08-05 2014-06-25 哈佛学院院长等 涉及核酸纳米和微米技术的组合物和方法
US9975916B2 (en) 2012-11-06 2018-05-22 President And Fellows Of Harvard College Compositions and methods relating to complex nucleic acid nanostructures
US10099920B2 (en) 2014-05-22 2018-10-16 President And Fellows Of Harvard College Scalable nucleic acid-based nanofabrication
WO2020011248A1 (zh) * 2018-07-12 2020-01-16 百药智达（北京）纳米生物技术有限公司 核酸纳米颗粒、包含其的药物组合物、含阿霉素的药物及其制备方法
CN110711254A (zh) * 2018-07-12 2020-01-21 百药智达（北京）纳米生物技术有限公司 核酸纳米颗粒及包含其的药物组合物
US10604543B2 (en) 2012-07-24 2020-03-31 President And Fellows Of Harvard College Self-assembly of nucleic acid nanostructures
CN110960530A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含他克林的药物、其制备方法、药物组合物及其应用
CN110960690A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含表柔比星的药物、其制备方法、药物组合物及其应用
CN110960534A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含五氟尿嘧啶的药物、其制备方法、药物组合物及其应用
CN110960542A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含吡柔比星的药物、其制备方法、药物组合物及其应用
CN110960536A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含阿司匹林的药物、其制备方法、药物组合物及应用
CN111053765A (zh) * 2018-10-16 2020-04-24 百药智达（北京）纳米生物技术有限公司 含紫杉醇的药物、其制备方法、药物组合物及应用
CN111068065A (zh) * 2018-10-22 2020-04-28 百药智达（北京）纳米生物技术有限公司 含奥沙利铂的药物、其制备方法、药物组合物及其应用
CN111084887A (zh) * 2018-10-23 2020-05-01 百药智达（北京）纳米生物技术有限公司 含黄酮的药物、其制备方法、药物组合物及应用
CN111096965A (zh) * 2018-10-29 2020-05-05 百药智达（北京）纳米生物技术有限公司 含双氢青蒿素的药物、其制备方法、药物组合物及其应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2015070080A2 (en) * 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Nucleic acid nanostructures for in vivo agent delivery
US11414694B2 (en) 2016-03-11 2022-08-16 Children's Medical Center Corporation Nucleic acid nanoswitch catenanes
CN115948505A (zh) 2016-08-02 2023-04-11 哈佛学院院长及董事 交叉协同自组装体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000813A1 (en) * 1983-08-03 1985-02-28 The Research Foundation Of State University Of New Nucleic acid branched junctions with precisely defined migrational mobility
US5386020A (en) * 1991-01-10 1995-01-31 New York University Multiply connected, three-dimensional nucleic acid structures
US5278051A (en) * 1991-12-12 1994-01-11 New York University Construction of geometrical objects from polynucleotides
US6072044A (en) * 1996-04-26 2000-06-06 New York University Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103889998A (zh) * 2011-08-05 2014-06-25 哈佛学院院长等 涉及核酸纳米和微米技术的组合物和方法
US9796749B2 (en) 2011-08-05 2017-10-24 President And Fellows Of Harvard College Compositions and methods relating to nucleic acid nano- and micro-technology
US10604543B2 (en) 2012-07-24 2020-03-31 President And Fellows Of Harvard College Self-assembly of nucleic acid nanostructures
US9975916B2 (en) 2012-11-06 2018-05-22 President And Fellows Of Harvard College Compositions and methods relating to complex nucleic acid nanostructures
US10099920B2 (en) 2014-05-22 2018-10-16 President And Fellows Of Harvard College Scalable nucleic acid-based nanofabrication
WO2020011248A1 (zh) * 2018-07-12 2020-01-16 百药智达（北京）纳米生物技术有限公司 核酸纳米颗粒、包含其的药物组合物、含阿霉素的药物及其制备方法
CN110711254A (zh) * 2018-07-12 2020-01-21 百药智达（北京）纳米生物技术有限公司 核酸纳米颗粒及包含其的药物组合物
CN110711254B (zh) * 2018-07-12 2022-07-26 百药智达（北京）纳米生物技术有限公司 核酸纳米颗粒及包含其的药物组合物
CN110960530B (zh) * 2018-09-30 2022-07-22 百药智达（北京）纳米生物技术有限公司 含他克林的药物、其制备方法、药物组合物及其应用
CN110960530A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含他克林的药物、其制备方法、药物组合物及其应用
CN110960542A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含吡柔比星的药物、其制备方法、药物组合物及其应用
CN110960536A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含阿司匹林的药物、其制备方法、药物组合物及应用
CN110960534A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含五氟尿嘧啶的药物、其制备方法、药物组合物及其应用
CN110960542B (zh) * 2018-09-30 2022-07-26 百药智达（北京）纳米生物技术有限公司 含吡柔比星的药物、其制备方法、药物组合物及其应用
CN110960536B (zh) * 2018-09-30 2022-07-26 百药智达（北京）纳米生物技术有限公司 含阿司匹林的药物、其制备方法、药物组合物及应用
CN110960690B (zh) * 2018-09-30 2022-07-22 百药智达（北京）纳米生物技术有限公司 含表柔比星的药物、其制备方法、药物组合物及其应用
CN110960690A (zh) * 2018-09-30 2020-04-07 百药智达（北京）纳米生物技术有限公司 含表柔比星的药物、其制备方法、药物组合物及其应用
CN110960534B (zh) * 2018-09-30 2022-07-26 百药智达（北京）纳米生物技术有限公司 含五氟尿嘧啶的药物、其制备方法、药物组合物及其应用
CN111053765A (zh) * 2018-10-16 2020-04-24 百药智达（北京）纳米生物技术有限公司 含紫杉醇的药物、其制备方法、药物组合物及应用
CN111053765B (zh) * 2018-10-16 2022-07-26 百药智达（北京）纳米生物技术有限公司 含紫杉醇的药物、其制备方法、药物组合物及应用
CN111068065A (zh) * 2018-10-22 2020-04-28 百药智达（北京）纳米生物技术有限公司 含奥沙利铂的药物、其制备方法、药物组合物及其应用
CN111068065B (zh) * 2018-10-22 2022-07-26 百药智达（北京）纳米生物技术有限公司 含奥沙利铂的药物、其制备方法、药物组合物及其应用
CN111084887B (zh) * 2018-10-23 2022-07-22 百药智达（北京）纳米生物技术有限公司 含黄酮的药物、其制备方法、药物组合物及应用
CN111084887A (zh) * 2018-10-23 2020-05-01 百药智达（北京）纳米生物技术有限公司 含黄酮的药物、其制备方法、药物组合物及应用
CN111096965B (zh) * 2018-10-29 2022-07-26 百药智达（北京）纳米生物技术有限公司 含双氢青蒿素的药物、其制备方法、药物组合物及其应用
CN111096965A (zh) * 2018-10-29 2020-05-05 百药智达（北京）纳米生物技术有限公司 含双氢青蒿素的药物、其制备方法、药物组合物及其应用

Also Published As

Publication number Publication date
BR0015484A (pt) 2002-07-02
HUP0203914A2 (en) 2003-03-28
CZ20021472A3 (cs) 2002-07-17
EP1228201A1 (en) 2002-08-07
AU2000101A (en) 2001-05-30
JP2003522524A (ja) 2003-07-29
MXPA02004727A (es) 2002-08-30
RU2002113755A (ru) 2004-01-10
NO20022231L (no) 2002-05-10
WO2001036624A1 (en) 2001-05-25
SK6042002A3 (en) 2002-12-03
AU782880B2 (en) 2005-09-08
KR20020059727A (ko) 2002-07-13
PL358811A1 (en) 2004-08-23
NO20022231D0 (no) 2002-05-10
HK1052529A1 (zh) 2003-09-19
CA2391084A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
CN1390253A (zh) 高级核酸型结构
US20220383976A1 (en) Stable nanoscale nucleic acid assemblies and methods thereof
Dinman Pathways to specialized ribosomes: the Brussels lecture
Famulok et al. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy
O'Sullivan Aptasensors–the future of biosensing?
Nilsen et al. Dendritic nucleic acid structures
Shukla et al. A boost for the emerging field of RNA nanotechnology: report on the first international conference on RNA nanotechnology
Tavitian In vivo imaging with oligonucleotides for diagnosis and drug development
Grabow et al. RNA modularity for synthetic biology
CN103946381A (zh) Ngf适体及其应用
Kopylov et al. Combinatorial chemistry of nucleic acids: SELEX
Ishikawa et al. GNRA/receptor interacting modules: versatile modular units for natural and artificial RNA architectures
Cai et al. Intercalated cytosine motif and novel adenine clusters in the crystal structure of the Tetrahymena telomere
JP5673992B2 (ja) 血管内皮細胞増殖因子結合性アプタマー
CN102171339A (zh) 针对ngf的适体及其用途
Lambert et al. Optimization of protein thermostability and exploitation of recognition behavior to engineer altered protein-DNA recognition
Zavyalova et al. DNA aptamer-based molecular nanoconstructions and nanodevices for diagnostics and therapy
US20050089893A1 (en) Methods and compositions for in vitro and in vivo use of parallel stranded hairpins and triplex structures as nucleic acid ligands
US20230220399A1 (en) Novel nucleic acid ligand and method for identifying same
Madkour Biotechnology of nucleic acids medicines as gene therapeutics and their drug complexes
ZA200204728B (en) High order nucleic acid based structures.
Cheng et al. Crystal structure of the PvuII restriction endonuclease
CN114438090B (zh) 特异性结合布鲁氏菌外膜蛋白Omp31核酸适配体及其用途
AU2014238740B2 (en) Aptamer to IL-17 and use thereof
Kagdiyal et al. A REVIEW ON THERAPEUTIC ANTISENSE MOLECULES AND APTAMERS AS DRUG OF FUTURE

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1052529

Country of ref document: HK